Illumina, Inc.

Archived Illumina, Inc. News

• MLL, IBM and Illumina collaborate to build new cognitive technology prototype for improving leukemia treatment
• Illumina debuts new software to optimize data analysis for noninvasive prenatal testing
• Equipment for single-cell genomics launched by Illumina and Bio-Rad
• NovaSeq, the new sequencer by Illumina, said to transform the field of genomics
• Illumina and IBM join forces to grow accessibility to genome data interpretation
• Illumina donates more than 95,000 human genetic variants to ClinVar database
• H3Africa Initiative selects Illumina to develop new array for genome-wide association studies
• Illumina signs initial customer deals for new Global Screening Array
• Genomics portfolio expanded by Illumina
• Merck KGaA, Darmstadt, Germany forms Global Fertility Alliance with Illumina and Genea
• HudsonAlpha buys Illumina HiSeq X Ten sequencing system
• Cypher Genomics, Illumina partner to facilitate development of genomic-based biomarkers
• Illumina launches VeriSeq PGS for preimplantation genetic screening of embryos
• WuXi Genome Center buys Illumina HiSeq X Ten sequencing system
• cfDNA testing lowers false positive rates and higher predictive values in general obstetric population
• Novogene purchases HiSeq X Ten sequencing system from Illumina
• Illumina inks multi-year supply agreement with LabCorp
• Illumina signs multi-year licensing agreement with Quest Diagnostics
• Illumina announces launch of TruGenome Undiagnosed Disease Test
• U.K. Organizations Partner With Illumina To Sequence 10,000 Whole Genomes
• Global Genomics Group Enlists Illumina For Cardiovascular Disease Study
• Illumina announces availability of its newest reagent kits for MiSeq benchtop sequencer
• HistoGenetics selects MiSeq sequencing system from Illumina for use in CLIA laboratory
• Illumina releases genomics cloud computing and storage platform
• Illumina releases TruSight Tumor for NGS-based somatic variant detection in solid tumors
• Illumina launches new RNA sequencing kits
• Eurofins MWG Operon acquires Illumina HiSeq 2500 and MiSeq sequencers
• U.S. District Court rules in favor of Illumina over Helicos lawsuit
• Illumina sues IBS and Qiagen for infringement of three patents
• Illumina launches new kits for targeted resequencing studies
• Illumina launches RapidTrack WGS service
• Illumina's new patent infringement suit targets Complete Genomics' cPal read technology
• Illumina launches Nextera XT DNA Sample Preparation Kits
• ISS recommends Illumina shareholders to vote against Roche's nominees
• Roche announces increase in offer price for outstanding Illumina shares
• CRG, Illumina partner for large-scale analysis of genetic variation and function
• Illumina launches new highly multiplexed cancer panel
• Roche extends cash tender offer to acquire all shares of Illumina
• Illumina introduces Cancer Analysis Service from IGN
• Roche proposes to acquire Illumina for $44.50 per share
• Illumina, UNTHSC enter next-generation sequencing collaboration in forensic DNA analysis
• Federal Circuit affirms dismissal of Illumina's patent infringement lawsuits against Affymetrix
• Illumina and University of Oxford collaborate to sequence whole genomes
• Illumina board authorizes new $100 million share repurchase program
• Illumina begins to ship HumanOmni5-Quad DNA Analysis BeadChip
• Illumina announces availability of new TruSeq Custom Enrichment kits
• Illumina, Sequenom sign three-year supply agreement
• Illumina announces price reduction in whole human genome sequencing projects
• Illumina prices 0.25% Convertible Senior Notes due 2016
• Illumina announces acquisition of Epicentre Biotechnologies
• Illumina announces next generation of iSelect custom genotyping products
• Court dismisses Illumina's patent infringement lawsuits against Affymetrix
• Illumina launches TruSeq sample preparation, Exome Enrichment kits for sequencing studies
• Illumina, Expression Analysis support Cancer GWAS and Data Analysis Grant program
• Illumina announces single flow cell version of HiSeq 2000 sequencing system
• Illumina 2010 third quarter revenue increases 50% to $237.3 million
• Helicos names Illumina and Life Technologies as additional defendants in lawsuit against Pacific Biosciences
• Covaris enters co-marketing partnership with Illumina for DNA shearing technologies
• Illumina launches TruSeq SBS Sequencing kit
• New pricing of $19,500 set for Illumina's individual genome sequencing service
• Illumina commences shipment of new HumanOmni2.5-Quad DNA Analysis BeadChip microarray
• FDA grants Illumina 510(k) clearance for VeraCode Genotyping Test for Factor V and Factor II
• FDA grants market clearance for Illumina's BeadXpress system for multiplex genetic analysis
• Illumina announces shipment of HiScanSQ system for research needs
• Illumina announces first named family DNA sequence
• Illumina launches VeraCode ADME Core Panel
• Illumina announces enhancement to OmniExpress BeadChip
• Illumina sequences DNA of American actress Glenn Close
• Illumina launches HumanOmniExpress BeadChip for GWAS
• LadaTech files patent infringement lawsuit against Illumina
• Illumina's Board of Directors authorize a new stock repurchase program
• EraGen Biosciences to have access to Illumina’s BeadXpress platform
• Broad Institute purchases 30 additional Genome Analyzers from Illumina
• Illumina announces 2010 roadmap for Infinium whole-genome genotyping platform
• New workflow automation system from Illumina
• Illumina and Solexa deny patent infringement allegations
• Illumina launches IlluminaCompute for its Genome Analyzer sequencing platform
• Illumina to defend Genome Analyzer System patent infringement suit
• Illumina delivers its first individual genome sequence to Dr. Hermann Hauser
• Illumina's new stock repurchase program effective in returning value to shareholders
• USPTO orders re-examination of two patents included in the patent litigation between Illumina and Affymetrix
• Illumina named as defendant in patent infringement suits
• Affymetrix files more patent infringements against Illumina in U.S. and Europe
• Illumina launches MicroRNA assay for gene expression profiling